We further examined the expression of SYCE2 in primary tumors by RT–PCR analysis using commercially available samples and found SYCE2 expression in the cervix, ovary, thyroid, and uterus tumor samples, and high expression in the normal testis. Here, SYCE2 is linked to medical procedure.